BLU2864

BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor (IC50=0.3 nM). BLU2864 shows anti-tumor activity. BLU2864 can be used in cancer and polycystic kidney disease research .


Cat. No.: EX-A8580	Purity: >98%

	Chemical structure of BLU2864

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	900	Inquire
250mg	1550	Inquire
500mg	2150	Inquire
1g	3350	Inquire
5g	9850	Inquire

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2810747-89-6
Purity	>98%
Formula	C24H19F3N4O2
Mol Weight	452.4285
Color	Off-white to light yellow
State	solid powder
Solubility	DMSO : 100 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1].Xiaofang Wang, et al. Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease. J Am Soc Nephrol. 2022 Jun;33(6):1087-1104. [2].Stefanie S. Schalm, et al. Evaluation of PRKACA as a Therapeutic Target for Fibrolamellar Carcinoma. bioRxiv 2022.01.31.477690.
CoA	CoA of BLU2864

Smiles:	O=C(C1=CN=C(C2=C3C(NC=C3C)=NC=C2)C=C1)N[C@@H]4C5=C(F)C=C(C(F)F)C=C5C[C@@H]4O


		Search